ROMÂNĂ

Back

 

 

Title of the project: BIOAMR (PN-III-P1-1.2-PCCDI-2017-0361: Bioeconomic approach to antimicrobial agents - use and resistance

 

 

Financing: State budget

 

The project is part of the PN III Program: 1 - Development of the national research-development system, being a Complex Project type project carried out in RDI consortia, Subprogram 1.2 - Institutional performance. The financing of the project is ensured from the state budget, having a total value of the contract of 5,287,500.00 lei and will take place over 30 months

 

Coordinator:

UNIVERSITATEA DE STIINTE AGRICOLE SI MEDICINA VETERINARA A BANATULUI "REGELE MIHAI I AL ROMANIEI" DIN TIMISOARA (USAMVBT)

 

Parteners:

SPITALUL CLINIC JUDETEAN DE URGENTA TIMISOARA (Oncogen)

UNIVERSITATEA BABES BOLYAI (UBB)

UNIVERSITATEA DE VEST TIMISOARA (UVT)

INSTITUTUL DE CERCETARE - DEZVOLTARE PENTRU PAJISTI (ICDP)

 

The bioeconomic approach of antimicrobial agents - use and resistance proposes an inter-institutional and systemic perspective of the use and resistance to antimicrobial preparations considering: i) economic efficiency, ii) environmental sustainability and iii) social acceptance of the actions of a macrosystem that includes human subsystems, animals, feed and the environment.

 

The aim of the project is to address, from a bio-economic perspective, the sensitivity and resistance of microorganisms to antimicrobial products in the subsystems that are part of the food chain.

 

The complex project consists of five component projects, as follows:

Project 1: Consolidation of the knowledge base and evidence by monitoring the consumption and screening of sensitivity to antimicrobial products

Project 2: An economic approach to bacterial resistance to antimicrobial agents

Project 3: Optimization of the use of antimicrobial preparations in the animal system

Project 4: Sensitivity and resistance of bacteria associated with antimicrobial agents in food, feed and environment

Project 5: Analysis of the network of resistance to antimicrobial agents: identification of critical nodes (HUBs) and cost-benefit analysis of the use, microbial resistance and diagnostic methods